Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
301 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Completed A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
Conditions: Lymphoma, Mantle-cell;   Leukemia, Lymphocytic, Chronic, B-Cell;   Leukemia, Hairy Cell;   Waldenstrom Macroglobulinemia;   Multiple Myeloma
Intervention: Drug: ON01910 Na
22 Active, not recruiting Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Conditions: Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome
Intervention: Other: Questionnaires, Laboratory tests, Abdominal MRI
23 Recruiting A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Conditions: CLL (Chronic Lymphocytic Leukemia);   SLL (Small Lymphocytic Lymphoma)
Interventions: Drug: Ibrutinib;   Drug: Fludarabine
24 Active, not recruiting Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Conditions: Recurrent Lymphoma;   Refractory Lymphoma;   Solid Tumours;   Central Nervous System
Interventions: Drug: Vinblastine;   Drug: Temsirolimus
25 Terminated Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
26 Completed Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Conditions: Fertility Preservation;   Alkylating Agents;   Lymphoma
Interventions: Drug: Triptorelin;   Drug: Norethisterone acetate
27 Terminated
Has Results
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Conditions: Burkitt Lymphoma;   Non-Hodgkins Lymphoma;   Atypical Burkitt Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Leucovorin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Mesna
28 Completed Psychosocial Impact of Cancer-Related Female Infertility
Conditions: Hodgkin's Disease;   Cervical Cancer;   Breast Cancer;   Lymphoma
Intervention: Behavioral: Telephone Survey
29 Completed
Has Results
Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Condition: T Cell Non-Hodgkin Lymphoma
Intervention: Drug: Imatinib mesylate
30 Active, not recruiting
Has Results
Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Bendamustine;   Drug: Cytarabine
31 Recruiting HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Conditions: Breast Cancer Female;   Breast Neoplasm;   Non-Hodgkin's B-cell Lymphoma;   Non-Hodgkin's Lymphoma, Adult High Grade;   NonHodgkin Lymphoma;   Diffuse Large B Cell Lymphoma;   Diffuse Large Cell Lymphoma, Adult;   Ovarian Cancer;   Ovarian Neoplasm;   Endometrial Cancer;   Endometrial Neoplasms;   Cervical Cancer;   Cervical Neoplasm;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer;   Fallopian Tube Neoplasms
Intervention:
32 Recruiting The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells
Condition: Cancer
Intervention:
33 Completed Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
Condition: Cancer
Interventions: Dietary Supplement: Vitamin D;   Dietary Supplement: Calcium
34 Recruiting Patient-Centered Decision Counseling for Women at Risk of Cancer-Related Infertility
Conditions: Malignant Neoplasm of Breast;   Malignant Neoplasm of Female Genital Organs;   Lymphoma;   Myeloma
Interventions: Behavioral: Questionnaires;   Other: Decision Aid Website;   Other: Educational Materials
35 Terminated Ph II CHOP+Velcade in Mediastinal LBCL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: bortezomib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Radiation: Radiation therapy
36 Terminated
Has Results
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Dietary Supplement: Arm A: Vitamin D3 Group;   Dietary Supplement: Placebo
37 Active, not recruiting A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
Conditions: Lung Cancer;   Non-Hodgkin Lymphoma;   Breast Cancer;   Stomach Cancer;   Brain Cancer
Intervention:
38 Completed
Has Results
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
Conditions: B-cell Lymphoma;   Indolent B-cell Lymphoma
Intervention: Drug: rituximab
39 Completed Cardiac Fibrosis by CMR in Patients With Cancer
Condition: Lymphoma
Intervention: Device: Cardiac Magnetic Resonance Scan
40 Completed
Has Results
Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
Conditions: Non-hodgkin Lymphoma;   Hodgkin Lymphoma
Interventions: Drug: Sirolimus;   Drug: Methotrexate;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: MMF

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.